Adenoviral-mediated gene transfer to synovial cells in vivo
    6.
    发明授权
    Adenoviral-mediated gene transfer to synovial cells in vivo 失效
    腺病毒介导的基因转移到体内滑膜细胞

    公开(公告)号:US5747072A

    公开(公告)日:1998-05-05

    申请号:US422655

    申请日:1995-04-14

    摘要: This invention provides recombinant adenoviral vectors having an expression control sequence operatively linked to a gene that encodes an anti-inflammatory polypeptide or that produces on transcription an anti-inflammatory ribozyme or antisense RNA molecule. This invention also provides methods of transferring a gene to a synovial cell by transducing the synovial cell in vivo, with a recombinant adenoviral vector. This invention also provides methods of treating an inflammatory condition in the joint of a subject comprising administering to the joint a therapeutically effective amount of a recombinant adenoviral vector having an expression control sequence operatively linked to a gene that encodes an anti-inflammatory polypeptide or that produces on transcription an anti-inflammatory ribozyme or antisense RNA molecule.

    摘要翻译: 本发明提供重组腺病毒载体,其具有与编码抗炎多肽或在转录上产生抗炎核酶或反义RNA分子的基因有效连接的表达调控序列。 本发明还提供了通过用体内重组腺病毒载体转导滑膜细胞将基因转移至滑膜细胞的方法。 本发明还提供了治疗受试者关节炎症状况的方法,包括给予关节治疗有效量的重组腺病毒载体,所述重组腺病毒载体具有与编码抗炎多肽的基因有效连接的表达调控序列,或产生 转录为抗炎核酶或反义RNA分子。